While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus. CEO Dr. Jonathan Javitt tells pharmaphorum about the science behind the company’s Zyesami, which targets the alveolar type II cells in the lung that are critical for transmission of oxygen. Zyesami was developed in conjunction […]

Like many biopharma companies, the global COVID-19 pandemic has caused delays while also offering opportunities for NeuroRx. The company is based in Radnor, Pennsylvania, and typically is focused on the central nervous system space, developing NRX-100/NRX-101, for suicidal bipolar depression and other neurological disorders. Those trials, however, were suspended because of the pandemic. But, during […]

Computer Scientist Dr. Lorien Pratt about “Link … How Decision Intelligence Connects Data, Actions, and Outcomes for a Better World.” Then Dr. Seth Lederman, the CEO of Tonix Pharmaceuticals, tells us about how PTSD affects the brain, its relation to sleep, and how it may treated some 9 years after the initial trauma. If you […]